null

SMILES CCc1csc(n1)[C@H](Cc1ccc(NS(O)(=O)=O)cc1)NC(=O)Cc1ccccc1

InChI Key InChIKey=JWIGAPIAAKCSFG-IBGZPJMESA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 359091   

TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 0.157nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2VT1VC9US Patent
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:HPTP-β inhibition can be tested by any method chosen by the formulator, for example, Amarasinge K. K. et al., “Design and Synthesis of Potent, N...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2VT1VC9US Patent
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 0.157nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00R3US Patent
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 0.157nMMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2RV0SPJ
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 0.157nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2668HD5US Patent
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Non-limiting examples of the HPTPβ IC50 (μM) activity.More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2668HD5US Patent
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2RV0SPJ
TargetReceptor-type tyrosine-protein phosphatase beta(Homo sapiens (Human))
AERPIO THERAPEUTICS, INC.

US Patent
LigandPNGBDBM359091(US10220048, Compound AA1 | US10220048, Compound AA...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Non-limiting examples of the HPTP-β IC50 (μM) activity.More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00R3US Patent